<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report a paracrine effect whereby endothelial cells (ECs) promote the <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> stem cell (<z:chebi fb="11" ids="17437,53115">CSC</z:chebi>) phenotype of human <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) cells </plain></SENT>
<SENT sid="1" pm="."><plain>We showed that, without direct cell-cell contact, ECs secrete factors that promoted the <z:chebi fb="11" ids="17437,53115">CSC</z:chebi> phenotype in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells via Notch activation </plain></SENT>
<SENT sid="2" pm="."><plain>In human <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> specimens, CD133 and Notch intracellular domain-positive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells colocalized in perivascular regions </plain></SENT>
<SENT sid="3" pm="."><plain>An EC-derived, soluble form of Jagged-1, via ADAM17 proteolytic activity, led to Notch activation in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cells in a paracrine manner; these effects were blocked by immunodepletion of Jagged-1 in EC-conditioned medium or blockade of ADAM17 activity </plain></SENT>
<SENT sid="4" pm="."><plain>Collectively, ECs play an active role in promoting Notch signaling and the <z:chebi fb="11" ids="17437,53115">CSC</z:chebi> phenotype by secreting soluble Jagged-1 </plain></SENT>
</text></document>